Results 1 to 10 of about 2,778,104 (252)
Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment [PDF]
Journal of Cardiovascular Development and Disease, 2022 Ischemic cardiovascular diseases have a high incidence and high mortality worldwide. Therapeutic advances in the last decades have reduced cardiovascular mortality, with antithrombotic therapy being the cornerstone of medical treatment.
Ignacio Barriuso +2 more
doaj +4 more sources
Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni [PDF]
Pharmaceuticals, 2021 The intravascular parasitic worm Schistosoma mansoni is a causative agent of schistosomiasis, a disease of great global public health significance. Praziquantel is the only drug available to treat schistosomiasis and there is an urgent demand for new ...
Raquel Porto +9 more
doaj +2 more sources
Risk of antidepressant initiation among users of cardiovascular agents and metformin. [PDF]
Pharmacology Research & Perspectives, 2023 Cardiovascular disease and diabetes are risk factors for depression, yet the relationship between the drug treatments for these diseases and the risk of antidepressant initiation remains unclear.
Ivana Bojanić +6 more
doaj +2 more sources
One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing [PDF]
MoleculesChronic wound treatments pose a challenge for healthcare worldwide, particularly for the people in developed countries. Chronic wounds significantly impair quality of life, especially among the elderly.
Anna Gościniak +4 more
doaj +2 more sources
Incretin analogues as cardiovascular agents: a state-of-the-art review [PDF]
Frontiers in EndocrinologyGlucagon-like peptide-1 (GLP-1) receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist tirzepatide have evolved over the past decade from glucose-lowering antidiabetic agents into a cardiovascular ...
Diego Araiza-Garaygordobil +6 more
doaj +2 more sources
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review [PDF]
Annals of Geriatric Medicine and Research, 2021 While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope ...
Sara Young, Enoch Chung, Michael A. Chen
doaj +1 more source
Anatolian Journal of Cardiology, 2023 Background: Elderly comprises a specific group due to possible alterations in the effects of drugs and comorbidities. We aimed to identify for the first time the characteristics and rates regarding the inappropriate prescriptions of cardiovascular system
Mehmet Tevfik Kitapçı +5 more
doaj +1 more source
The evidence for a role of bacteria and viruses in cardiovascular disease [PDF]
Scripta Medica, 2022 Inflammation plays a critical role in atherosclerosis and cardiovascular disease. Bacteria and viruses are major causative agents of inflammation in the body which normally develops as a response to infection.
Pierce Grant N. +5 more
doaj +1 more source
Persistence and Adherence to Cardiovascular Medicines in Australia
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa +5 more
doaj +1 more source
Frontiers in Pediatrics, 2021 We aimed to determine the association of vasoactive-inotropic score (VIS) and vasoactive-ventilation-renal (VVR) score with in-hospital mortality and functional outcomes at discharge of children who receive ECMO.
Ira Shukla +3 more
doaj +1 more source